LDLR and familial hypercholesterolemia: Given that functional mutations within the LDL receptor represent the primary genetic cause of familial hypercholesterolemia, one would expect that much effort has been put into utilizing CRISPR/Cas9 technology to correct pathogenic defects in the LDL receptor prevalent in humans.